Romosozumab (bone forming agent) could be a new method for growing bones.

[Deleted member 276978]

Romosozumab increases bone formation by inhibiting sclerostin, and this mechanism can increase bone mass in any individual, regardless of baseline bone density. Though when not prescribed it’s hard to get your hands on.

Here’s a study:

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial - PubMed

The Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial (NCT01631214; https://clinicaltrials.gov/ct2/show/NCT01631214) showed that romosozumab for 1 year followed by alendronate led to larger areal bone mineral density (aBMD) gains and superior...

pubmed.ncbi.nlm.nih.gov

 

[Deleted member 254297]

bone mass does NOT equal bone growth/size

 

[Deleted member 276978]

It does increase bone thickness as well lol

 

[nosecel (sec acc)]

no it doesn't work like that

 

[Deleted member 254297]

It does increase bone thickness as well lol

show quote in study

 

[Deleted member 276978]

My bad I uploaded the wrong study, I’ve read a couple. I will upload an updated version of this one.

 

[Deleted member 289045]

Romosozumab increases bone formation by inhibiting sclerostin, and this mechanism can increase bone mass in any individual, regardless of baseline bone density. Though when not prescribed it’s hard to get your hands on.

Here’s a study:

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial - PubMed

The Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial (NCT01631214; https://clinicaltrials.gov/ct2/show/NCT01631214) showed that romosozumab for 1 year followed by alendronate led to larger areal bone mineral density (aBMD) gains and superior...

pubmed.ncbi.nlm.nih.gov

it can also risk heart attacks, strokes, and cardiovascular-related death.